33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemotherapy and inflammation induced damage of intestinal epithelium is associated with increased T cell chemotaxis
    Meeting Abstract

    Jansen, S. A.; van Hoesel, M.; Mokry, M.; Sierra, L. S.; Takashima, S.; Nieuwenhuis, E. E.; Hanash, A. M.; Lindemans, C. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: Ongoing phase III SIERRA trial experience at 6 study sites
    Meeting Abstract

    Nath, R.; Chu, B.; Chen, L.; Sadeghi, A.; Senglaub, T.; Kaiser, L.; Saganich, C.; Zgaljardic, M.; Rutar, F.; Harling, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prediction of non-relapse mortality with dynamic EASIX scores after allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Perales, M.; Giralt, S. A.; Scordo, M.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early CD4+ T-cell reconstitution is an excellent predictor for survival and non-relapse mortality in pediatric and young adult patients who develop moderate to severe acute graft-versus-host-disease; a dual center validation
    Meeting Abstract

    de Koning, C.; Prockop, S. E.; Van Roessel, I.; Klein, E.; Boulad, F.; Kernan, N. A.; Scaradavou, A.; Curran, K. J.; Spitzer, B.; Cancio, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of and decreased inpatient hospital days for non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) patients with outpatient BEAM using daily etoposide and cytarabine and autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Cavalier, K.; Cazeau, N.; Bhatt, V.; McElrath, C.; LeStrange, N. J.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of conditioning regimens for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K. T.; Lin, A.; Ruiz, J. D.; Zheng, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Sauter, C. S.; Perales, M.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Acute kidney injury in allogeneic hematopoietic transplant recipients
    Meeting Abstract

    Abramson, M.; Gutgarts, V.; Zheng, J.; Ruiz, J. D.; Maloy, M. A.; Jaimes, E. A.; Scordo, M.; Sathick, I. J.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save